Skip to main navigation Skip to search Skip to main content

Bedaquiline targets the ε subunit of mycobacterial F-ATP synthase

  • Subhashri Kundu
  • , Goran Biukovic
  • , Gerhard Grüber
  • , Thomas Dick
  • National University of Singapore
  • Nanyang Technological University

Research output: Contribution to journal › Article › peer-review

69 Scopus citations

Abstract

The tuberculosis drug bedaquiline inhibits mycobacterial F-ATP synthase by binding to its c subunit. Using the purified ε subunit of the synthase and spectroscopy, we previously demonstrated that the drug interacts with this protein near its unique tryptophan residue. Here, we show that replacement of ε's tryptophan with alanine resulted in bedaquiline hypersusceptibility of the bacteria. Overexpression of the wild-type ε subunit caused resistance. These results suggest that the drug also targets the ε subunit.

Original languageEnglish
Pages (from-to)6977-6979
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume60
Issue number11
DOIs
StatePublished - 1 Nov 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Bedaquiline targets the ε subunit of mycobacterial F-ATP synthase'. Together they form a unique fingerprint.

Cite this